Startup India Government of India
Zivira Labs Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹38.07 Cr
▲ 22% YoY
Net profit · FY 2025
₹47.8 Lakh
Net margin 1.3%
EBITDA · FY 2025
₹99.93 Lakh
EBITDA margin 2.6%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹88.45 Lakh
Issued & subscribed
Open charges
₹5 Cr
Satisfied ₹5.32 Cr
Company age
9 yrs
Est. 2017
Employees · EPFO
112
Provident fund records
About Zivira Labs Private Limited
Data last updated:
Zivira Labs Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U36109MH2017PTC299902. Its GSTIN is 27AABCZ1291Q1ZO (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹88.45 Lakh. It is led by directors including Ponnuraman Tamil Kumaran (Managing Director) and Catherine Danan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.07 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹47.8 Lakh (net margin 1.3%) and EBITDA of ₹99.93 Lakh (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 25% over five years.
The company has about 112 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹5 Cr and satisfied charges of ₹5.32 Cr on record.
Zivira Labs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0009073). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zivira.co.in.
Company details
CIN U36109MH2017PTC299902
Registration Number 299902
Incorporation Date 19 September 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-MH-19-0009073
Key People
Ponnuraman Tamil Kumaran Managing Director Catherine Danan Director Prashanth Janardhan Rao Director Recognitions & Rankings of Zivira Labs
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0009073
Contact details
Zivira Labs Private Limited's registered office is in Mumbai, Maharashtra. Its website is zivira.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit No. 906 9th Floor Eco Star Near Udipi Vihar Restaurant Vishweshwar, Nagar, Mumbai, Maharashtra, India – 400063
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zivira Labs Private Limited, buy the company report.
Comprehensive company report
Zivira Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Zivira Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Zivira Labs Private Limited, buy the company report.
Financials of Zivira Labs Private Limited
FY 2025 filings availableZivira Labs Private Limited reported revenue of ₹38.07 Cr (up 22% YoY) for FY 2025.
Revenue · FY 2025
₹38.07 Cr ▲ 22%
Net profit · FY 2025
₹47.8 Lakh margin 1.3%
EBITDA · FY 2025
₹99.93 Lakh margin 2.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 26%
5 years · compounded
▲ 25%
EBITDA CAGR growth
1 year
▲ 73%
3 years · compounded
▲ 29%
5 years · compounded
▲ 28%
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 22% growth in the latest year. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹99.93 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹47.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zivira Labs Private Limited, buy the company report.
Board of directors of Zivira Labs Private Limited
Zivira Labs has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Catherine Danan Also directs: Vuefos Biotech LLP | Director | 21 Feb 2020 | 6 Years 8 Months | Current |
| Prashanth Janardhan Rao | Director | 21 Feb 2020 | 6 Years 8 Months | Current |
| Poosaikannu Sundarashanthi | Director | 19 Sep 2017 | 9 Years 1 Months | Current |
| Ponnuraman Tamil Kumaran | Managing Director | 19 Sep 2017 | 9 Years 1 Months | Current |
Peer comparison
Zivira Labs Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Klar Sehen Pvt Ltd | ₹38.16 Cr (FY 2016) | 18.0% | Bidar, Karnataka, India | |||
| Tulip Lab Private Limited | ₹38.12 Cr (FY 2023) | -78.0% | Mumbai, Maharashtra, India | |||
| Biomax Biotechnics Private Limited | ₹38.1 Cr (FY 2025) | 9.0% | Chandigarh, India | |||
| Zivira Labs Private Limitedthis company | ₹38.07 Cr (FY 2025) | ₹47.8 Lakh | 1.3% | 22.0% | 112 | Mumbai, Maharashtra, India |
| VVR Organics Private Limited | ₹38.01 Cr (FY 2024) | 9.0% | Hyderabad, Telangana, India | |||
| Purogene Labs Private Limited | ₹37.79 Cr (FY 2025) | 36.0% | Hyderabad, Telangana, India | |||
| Ivpex Parenteral Private Limited | ₹37.61 Cr (FY 2025) | 5.0% | Baddi, Himachal Pradesh, India | |||
| Titanium Technologies (India) Private Limited | ₹37.49 Cr (FY 2024) | 60.0% | New Delhi, Delhi, India |
To see the full peer comparison of Zivira Labs Private Limited, buy the company report.
Auditor
Zivira Labs Private Limited is audited by KOLATH & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KOLATH & CO | FY 2023 | 008926S |
Shareholding
The shareholding of Zivira Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zivira Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Cr
Satisfied charges
₹5.32 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Mar 2025 | 101078446 | Others | ₹5 Cr | Open | |
| 14 Mar 2022 | 100568129 | Axis Bank Limited | ₹3.57 Cr | Satisfied | |
| 01 Mar 2021 | 100422942 | Others | ₹15.03 Lakh | Satisfied | |
| 23 Dec 2019 | 100315235 | Others | ₹1.6 Cr | Satisfied |
To see the full charge records of Zivira Labs Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Zivira Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Zivira Labs Private Limited has 5 MSME Form 1 returns on record between 2023 and 2024, listing 61 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Sunbeam Lifesciences Private Limited | |||
| Carenow Medical Private Limited | |||
| an individual supplier | |||
| Renova Lifesciences Private Limited |
To see the full MSME payment records of Zivira Labs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Zivira Labs Private Limited has a workforce of 112 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
Employee count
112
Active EPFO establishments
1
Employee growth
14.29%
GST
Zivira Labs has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCZ1291Q1ZO | Maharashtra | Active | 07 Nov 2017 |
| 33AABCZ1291Q1ZV | Tamil Nadu | Active | 28 Nov 2017 |
To see the full GST registrations and return filing status of Zivira Labs Private Limited, buy the company report.
Recent activity
Zivira Labs Private Limited has 6 board changes on record since 2017: 4 appointments and 2 cessations. The latest: Catherine Danan ceased to be Additional Director on 31 Dec 2020.
AGM
Zivira Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 14 Mar 2022 via Charge ID 100568129 with Axis Bank Limited was fully satisfied on 24 Apr 2025.
Filing
Zivira Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101078446 was registered on 21 Mar 2025.
Charges
A charge with Axis Bank Limited of Rs. 3.57 Cr registered on 14 Mar 2022 with Charge ID 100568129 was modified on 29 May 2024.
Charges
A charge registered on 01 Mar 2021 via Charge ID 100422942 with Others was fully satisfied on 18 Sep 2023.
Charges
A charge registered on 23 Dec 2019 via Charge ID 100315235 with Others was fully satisfied on 16 Mar 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 3.57 Cr with Charge ID 100568129 was registered on 14 Mar 2022.
Charges
A charge with Others amounted to Rs. 0.15 Cr with Charge ID 100422942 was registered on 01 Mar 2021.
Ceased
Catherine Danan ceased to be Additional Director.
Ceased
Prashanth Janardhan Rao ceased to be Additional Director.
Appointed
Catherine Danan was appointed as Director.
5 earlier events are in the company report.
Frequently asked questions
Zivira Labs is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 September 2017 (9+ years old) and is registered under CIN U36109MH2017PTC299902.
Zivira Labs has 4 current directors:
- Ponnuraman Tamil Kumaran - Managing Director
- Catherine Danan - Director
- Prashanth Janardhan Rao - Director
- Poosaikannu Sundarashanthi - Director
The latest financial statements of Zivira Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Zivira Labs is 27AABCZ1291Q1ZO, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 33AABCZ1291Q1ZV (Tamil Nadu).
The CIN (Corporate Identification Number) of Zivira Labs is U36109MH2017PTC299902. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zivira Labs was incorporated on 19 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Zivira Labs by revenue are Klar Sehen Pvt Ltd, Tulip Lab Private Limited, Biomax Biotechnics Private Limited, VVR Organics Private Limited, Purogene Labs Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Catherine Danan ceased to be Additional Director on 31 Dec 2020. Prashanth Janardhan Rao ceased to be Additional Director on 31 Dec 2020. Catherine Danan was appointed as Director on 21 Feb 2020. Zivira Labs has 6 board changes on record in total.
Yes, Zivira Labs is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Zivira Labs is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0009073).
Zivira Labs has 5 MSME Form 1 returns on record between 2023 and 2024, listing 61 overdue payments to 8 micro and small suppliers. The latest return was filed on 25 Apr 2024.
Zivira Labs can be reached through the website zivira.co.in. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages